SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Ligand (LGND) Breakout!
LGND 197.01-2.9%Dec 1 3:59 PM EST

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: jayhawk969 who wrote (28618)3/31/1999 2:28:00 PM
From: Cheryl Galt  Read Replies (1) of 32384
 
Hi J.D. Yes, the quarter's earnings were well discussed, and the first wave of dilution due to the merger and the Elan deal, and the dilution due August 2nd.

And i think we know that the one-time write-offs for in-process technology were
$15M for Morphelan in 4Q and $30M for Ontak in 3Q.

But look!
Stockholders' Equity slipped from $35.35M at end of 1997
to negative $11.36M at end of 1998 -- quite a dubious distinction.

And when i compare the current balance sheet to the one from 3Q 98,
there's much i don't understand, and i hope you can help.
-----------------

At end of 3Q98, Ligand had cash, cash equivalents, short-term investments and restricted cash of $43.6M.
At end of 4Q98, that GREW to $72.5 million. Very nice!!

But where'd the ~$30M come from ???

Since the 3Q,
o the converts debt is about the same.
o Accrued acquisition obligation is the same (37 + 3 + 10).
o Current liabilities is up ~$8M.
o Long-term debt is up ~$40M

Any suggestions anyone ?
Is there some kind of private financing going on??

TIA
Cheryl

PS - J.D., I didn't notice any leak-related selloff.
I thought Ligand was swinging intra-day on [8.5 - 9.25] since the Lilly announcement.
What am i missing?
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext